AlphaStocks
4.3
Weak

Zoetis Inc. (ZTS)

As of Sep 20, 2026, Zoetis Inc. (ZTS) scores 4.3/10 on AlphaStocks' five-model composite, #131 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P 500

$71.46

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#131out of 168 in Health Care

Is Zoetis Inc. a Good Investment in 2026?

Zoetis Inc. (ZTS) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Zoetis Inc. as Strong (7/9). The Graham model is the least favorable, rating it Neutral. Zoetis Inc. ranks #131 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E11.9ROE60.7Market Cap30BDiv Yield2.7

Valuation

Trades at 12x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Attractive

PEG 0.6 · Fast Grower

Greenblatt

Strong

Earnings yield 14.1% · ROC 69%

Frequently Asked Questions

Is Zoetis Inc. (ZTS) a good investment?
As of Sep 20, 2026, Zoetis Inc. (ZTS) scores 4.3/10 on AlphaStocks' five-model composite, #131 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 12x earnings — near sector median of 30x.
What is Zoetis Inc.'s Piotroski F-Score?
Zoetis Inc.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ZTS overvalued or undervalued?
A precise fair value estimate is not available for ZTS. Trades at 12x earnings — near sector median of 30x.
How does ZTS compare to other Health Care stocks?
Zoetis Inc. ranks #131 out of 168 stocks in the Health Care sector, placing it in the top 78% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ZTS?
AlphaStocks evaluates ZTS using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 4.3/10.

Similar Stocks

Compare ZTS with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer